See analyst estimates and all valuation multiples for Bioindustrials
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $42.1B | 1.6x | 7.6x | |
| $17.7B | 4.1x | 16.0x | |
| $16.1B | 2.7x | 6.9x | |
| $12.3B | 0.8x | 5.5x | |
| $9.9B | 4.6x | 10.7x | |
| $9.8B | 3.3x | 8.9x | |
| $8.4B | 2.0x | 9.4x | |
| $6.5B | 3.1x | 9.3x | |
| $6.0B | 6.3x | 23.0x | |
| $3.0B | 0.7x | 4.6x | |
| $2.8B | 0.8x | -70.2x | |
| $2.1B | 2.4x | 13.8x | |
| $1.8B | 1.2x | 8.5x | |
| $1.3B | 2.5x | n/a | |
| $1.2B | 3.5x | 19.2x | |
| $638M | 0.6x | n/a | |
| $537M | 1.4x | 9.4x | |
| $441M | 1.8x | 11.8x | |
| $433M | 1.4x | 8.5x | |
| $316M | 0.6x | 7.0x | |
| $313M | 0.6x | 2.0x | |
| $199M | 3.2x | -4.3x | |
| $87.5M | 18.6x | -0.5x | |
| $86.9M | 601.5x | -15.0x | |
| $67.4M | 6.5x | 143.0x | |
| $52.2M | 3.5x | -8.1x | |
| $27.7M | 6.2x | n/a | |
| $25.5M | n/a | n/a | |
| $14.8M | 2.4x | -7.7x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Bioindustrials